Last Week in Cannabis #21
Canada set another monthly sales record at $520.4 million in August, Israel named four specific Canadian cannabis companies in its anti-dumping investigation, and a new Massachusetts poll shows 71% of voters opposing the cannabis repeal ballot measure. Here’s this week’s global cannabis news, simply explained.
Beginner's Guide to Cannabis and Sleep
Cannabis and sleep have a complicated relationship. Here's an honest, research-grounded beginner's guide — including what works, what doesn't, and what to be careful about.
CBN and Sleep: Simply Explained
CBN is one of the most hyped cannabinoids for sleep right now. The first clinical trial specifically testing it in people with diagnosed insomnia just published — and the results are more complicated than the marketing suggests. Here's what it actually found.
Last Week in Cannabis #20
Eight years of cannabis legalization in Canada — and the Aurora takeover just got a third bidder with British American Tobacco money behind it. Plus Canada launched online cannabis pardons and a clinical trial found a cannabis formulation cut morphine use by nearly 50%. Here’s this week’s global cannabis news, simply explained.
Beginner's Guide to Microdosing Cannabis
Microdosing cannabis is one of the most accessible approaches for people who want the potential benefits without getting high. Here's how it works.
Cannabis and Parkinson’s Disease: Simply Explained
Parkinson's disease causes more than movement problems — pain, disrupted sleep, and nighttime urination are among the most quality-of-life-affecting symptoms. A 2026 study followed 68 patients using medical cannabis for three months. Here's what they found.
Last Week in Cannabis #19
Cannabis is now Canada’s fifth-largest cash crop at $3 billion in farm receipts, Curaleaf raised its Aurora takeover offer by 25%, Manitoba removed its cannabis store window-covering requirement, and the DEA formally confirmed there are no known cannabis overdose deaths. Here’s this week’s global cannabis news, simply explained.
Beginner's Guide to CBD
CBD is one of the most searched topics in cannabis — and one of the most misunderstood. Here's everything a beginner needs to know to get started safely and confidently.
THC, CBD and Dementia Agitation: Simply Explained
A landmark 2026 clinical trial found a THC and CBD combination reduced agitation in nearly 90% of late-stage dementia patients — a response rate researchers said had never been seen before in dementia trials. Here's what that means and what comes next.
Last Week in Cannabis #18
Six Canadian cannabis companies made the Globe and Mail's Top Growing Companies list, the DEA cannabis rescheduling process hit another procedural delay, and New York's legal cannabis market crossed $4 billion in total sales. Here's this week's global cannabis news, simply explained.
Medical vs Recreational Cannabis in Canada
Most Canadians don't realize there are two separate cannabis systems — recreational and medical. Here's what's different between them and why it might matter for you.
Cannabis and Fibromyalgia Long-Term: Simply Explained
Earlier this month we covered a study where CBD didn't outperform placebo for fibromyalgia. This month: a real-world study of 497 patients over 18 months that tells a more complicated story. Here's what the long-term data actually shows.
Last Week in Cannabis #17
Aurora Cannabis took Curaleaf to the Alberta Securities Commission, Health Canada proposed cutting cannabis tracking red tape, and Massachusetts voters will decide in November whether to become the first state to repeal cannabis legalization. Here's this week's global cannabis news, simply explained.
Beginner's Guide to Edibles
Edibles are one of the most popular ways to use cannabis in Canada — and one of the easiest to misuse. This guide covers everything a first-timer needs to know.
CBD and PTSD-Simply Explained
Cannabis and PTSD is a complicated conversation — and an important one. The first randomized clinical trial produced surprising results. Here's what the research actually found, what it means, and why the most interesting finding might not be the one you'd expect.
Last Week in Cannabis #16
High Tide posted its fifth consecutive record quarter with $198.8 million in revenue, the Aurora-Curaleaf takeover drama keeps escalating, and Quebec's cannabis industry is publicly calling out the Premier. Here's this week's global cannabis news, simply explained.
What Is a Cannabis Strain? Simply Explained
You'll hear the word "strain" the moment you walk into a dispensary — but what does it actually mean, and how much should it guide your choices? Here's the plain-language version.
CBD, CBG and Eczema: Simply Explained
Eczema affects millions of people and is notoriously hard to manage long-term. A 2025 study tested a CBD and CBG ointment on eczema patients for eight weeks. Here's what they found — and what to keep in mind about the limitations.
Last Week in Cannabis #15
The largest-ever review of cannabis legalization and substance use is out of McGill, cannabis beverages are helping people cut their alcohol intake roughly in half, and High Tide is about to hit 232 stores nationally. Here's this week's global cannabis news, simply explained
Is Cannabis Safe for Seniors?
Cannabis use among older Canadians has grown significantly since legalization. Here's an honest, practical guide for seniors — and for the family members who have questions on their behalf.